{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$11.90 vs. cons $11.67",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4.27B vs. cons $4.23B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA / margin (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.93B (~45.6% margin) vs. cons ~$1.93B (~45.5% margin)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Total Revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$17.0B-$17.6B (~$17.3B midpoint) vs. cons ~$17.2B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Adjusted EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$7.7B-$7.95B (~$7.82B midpoint) vs. cons ~$7.75B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Free Cash Flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.15B-$2.45B (~$2.30B midpoint) vs. cons ~$2.30B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Total shareholder return (buybacks+dividends)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.0B (~$32/share) vs. prior stated plan ~$2.0B (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A modest EPS/revenue beat plus an in-line-to-slightly-better EBITDA margin print, paired with a small full-year revenue/EBITDA guidance raise (the third straight upward revision after Q1's beat-and-raise), should nudge out-quarter Street estimates higher rather than trigger the implicit-cut dynamic that hurt the stock after Q4 2025's margin miss. With sell-side targets already trending up into the print (Citi, JPM) and the stock having de-risked ~10% off its late-June high, a clean-but-not-blowout quarter likely sees the initial pop extend modestly over the week as analysts lift 2026/2027 EPS models, rather than fade, unless specialty-segment margin commentary disappoints.",
  "day5_confidence": "MEDIUM"
}